Cyclosporin A (CyA) does not enhance CFU-c growth in patients with severe aplastic anaemia

Scand J Haematol. 1985 Feb;34(2):133-6. doi: 10.1111/j.1600-0609.1985.tb02245.x.

Abstract

8 patients with severe aplastic anaemia (SAA) in remission following immunosuppressive therapy were studied for CFU-c growth from unfractionated or E-rosette depleted (E-) bone marrow (BM) cells. Cyclosporin A (CyA) was added to unfractionated BM cells at a concentration of 1000 ng/ml. The mean number of CFU-c/10(5) BM cells plated was 6 +/- 6 from unfractionated BM cells, 28 +/- 20 from E-BM cells, and 8 +/- 7 from unfractionated BM cells supplemented with CyA. All patients had significant increase of CFU-c growth after E rosette depletion (overall P = 0.002). On the contrary, only 1 patient showed an increase of CFU-c growth after addition of CyA, and overall there was no difference between untreated and CyA treated BM cells (P = 0.7). These results suggest that addition of CyA to BM cells in vitro is not an effective means of enhancing CFU-c growth in SAA patients.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / drug therapy
  • Anemia, Aplastic / immunology
  • Anemia, Aplastic / pathology*
  • Bone Marrow / pathology
  • Cell Separation
  • Colony-Forming Units Assay
  • Cyclosporins / pharmacology*
  • Female
  • Hematopoiesis / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Rosette Formation
  • T-Lymphocytes, Regulatory / cytology*

Substances

  • Cyclosporins